Patents Assigned to Vaxcyte, Inc.
  • Patent number: 12280097
    Abstract: The present disclosure provides a cell-free method for synthesizing an Invasion Plasmid Antigen B (IpaB) antigen associated with a Shigella bacterium comprising exogenous addition of the purified chaperone protein IpgC to the cell-free synthesis mixture. The disclosure further provides IpaB antigen mutants comprising non-natural amino acids incorporated during cell-free synthesis, enabling covalent conjugation to a Shigella O-antigen polysaccharide. Further provided are Ipa B antigens and conjugates thereof, as well as immunogenic compositions prepared with the synthesized IpaB antigens and conjugates thereof and methods of use.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: April 22, 2025
    Assignee: Vaxcyte, Inc.
    Inventors: Neeraj Kapoor, Jeffery C. Fairman
  • Patent number: 12252454
    Abstract: The present disclosure provides methods of preparing heteroaryl-containing compounds, wherein an azide-alkyne cycloaddition is accelerated in the presence of lauryldimethylamine oxide (LDAO). The present disclosure further provides conjugates of polypeptides and antigens prepared using such methods.
    Type: Grant
    Filed: February 17, 2023
    Date of Patent: March 18, 2025
    Assignee: Vaxcyte, Inc.
    Inventors: Jeffery C. Fairman, Neeraj Kapoor, Lucy Estella Pill, Scott Snyder
  • Patent number: 12121575
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Grant
    Filed: May 30, 2023
    Date of Patent: October 22, 2024
    Assignee: Vaxcyte, Inc.
    Inventor: Jeffery Fairman
  • Patent number: 11998599
    Abstract: Methods for the production of immunogenic compositions containing a non-natural amino acid are disclosed. The non-natural amino acid can be a site for attachment of antigens, such as bacterial capsular polysaccharides, to make immunogenic conjugates. Bio-orthogonal attachment chemistry incorporated into the non-natural amino acids allows for more efficient and potent antigen presentation to the immune system, simplified purification, and more well-defined structure of these semi-synthetic immunogens.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: June 4, 2024
    Assignee: Vaxcyte, Inc.
    Inventors: Jeffery Fairman, Jon H. Heinrichs, Wei Chan
  • Patent number: 11951165
    Abstract: Methods for the production of immunogenic compositions containing a non-natural amino acid are disclosed. The non-natural amino acid can be a site for attachment of antigens, such as bacterial capsular polysaccharides, to make immunogenic conjugates. Bio-orthogonal attachment chemistry incorporated into the non-natural amino acids allows for more efficient and potent antigen presentation to the immune system, simplified purification, and more well-defined structure of these semi-synthetic immunogens.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 9, 2024
    Assignee: Vaxcyte, Inc.
    Inventors: Jeffery C. Fairman, Jon H. Heinrichs, Wei Chan
  • Patent number: 11701414
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: July 18, 2023
    Assignee: Vaxcyte, Inc.
    Inventor: Jeffery Fairman
  • Publication number: 20220389476
    Abstract: The present disclosure provides methods, compositions, and kits for in vitro cultivation of catalase-negative bacteria. The present disclosure further provides catalase-negative bacteria cultivated according to the methods described herein and bacterial stocks thereof.
    Type: Application
    Filed: May 18, 2022
    Publication date: December 8, 2022
    Applicant: Vaxcyte, Inc.
    Inventor: Peter DAVEY
  • Patent number: 10835590
    Abstract: An immunogenic composition, a periodontal vaccine formulation containing the immunogenic composition, and methods for treating or preventing periodontal disease are provided, where the methods involves administering an immunologically effective amount of the composition or vaccine formulation to a subject.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: November 17, 2020
    Assignee: Vaxcyte, Inc.
    Inventor: Jeffery Fairman